Total Payments
$9,120
2023 Payments
$51.66
Companies
42
Transactions
630
Medicare Patients
1,707
Medicare Billing
$166,451
Payment Breakdown by Category
Food & Beverage$8,955 (98.2%)
Education$164.93 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,955 | 619 | 98.2% |
| Education | $164.93 | 11 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,401 | 123 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,192 | 71 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $758.58 | 58 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $480.11 | 45 | $0 (2021) |
| Amarin Pharma Inc. | $466.26 | 23 | $0 (2021) |
| AbbVie Inc. | $417.29 | 31 | $0 (2021) |
| Amgen Inc. | $403.43 | 26 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $393.53 | 19 | $0 (2020) |
| Astellas Pharma US Inc | $384.67 | 22 | $0 (2020) |
| Lilly USA, LLC | $366.07 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $51.66 | 3 | Inspire Medical Systems, Inc. ($21.10) |
| 2021 | $1,929 | 115 | Novo Nordisk Inc ($568.06) |
| 2020 | $1,362 | 99 | Novo Nordisk Inc ($315.12) |
| 2019 | $1,502 | 112 | AstraZeneca Pharmaceuticals LP ($292.51) |
| 2018 | $1,988 | 142 | AstraZeneca Pharmaceuticals LP ($295.81) |
| 2017 | $2,287 | 159 | AstraZeneca Pharmaceuticals LP ($368.12) |
All Payment Transactions
630 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: NEUROLOGY | ||||||
| 06/02/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Inflammation | ||||||
| 05/31/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Diabetes | ||||||
| 11/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Diabetes | ||||||
| 11/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: Diabetes | ||||||
| 11/18/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Neuroscience | ||||||
| 11/17/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiovascular | ||||||
| 11/10/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Diabetes | ||||||
| 11/09/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 11/08/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $20.79 | General |
| Category: Cardiovascular | ||||||
| 11/03/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Gastroenterology | ||||||
| 11/03/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: DIABETES | ||||||
| 11/03/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: Diabetes | ||||||
| 11/01/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Respiratory | ||||||
| 10/28/2021 | AbbVie Inc. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/25/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $85.55 | General |
| Category: Diabetes | ||||||
| 10/21/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Cardiovascular | ||||||
| 10/20/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: Diabetes | ||||||
| 10/12/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, JANUMET | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: DIABETES | ||||||
| 10/06/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: Diabetes | ||||||
| 09/30/2021 | AbbVie Inc. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/30/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Obesity | ||||||
| 09/28/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 120 | 201 | $36,739 | $14,810 |
| 2021 | 13 | 725 | 1,379 | $144,578 | $75,548 |
| 2020 | 13 | 862 | 1,677 | $171,270 | $76,093 |
Total Patients
1,707
Total Services
3,257
Medicare Billing
$166,451
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 178 | $33,669 | $13,752 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 23 | $3,070 | $1,058 | 34.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 220 | 640 | $96,320 | $51,619 | 53.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 63 | 63 | $11,970 | $8,124 | 67.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 57 | 186 | $12,090 | $5,139 | 42.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 86 | $9,676 | $4,484 | 46.3% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 81 | 81 | $2,835 | $2,213 | 78.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 76 | 76 | $2,122 | $1,252 | 59.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 68 | 130 | $5,200 | $1,214 | 23.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 22 | 24 | $1,740 | $876.11 | 50.4% |
| 96138 | Psychological or neuropsychological test administration and scoring by technician, first 30 minutes | Office | 2021 | 13 | 13 | $546.00 | $245.60 | 45.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 18 | $540.00 | $176.64 | 32.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 13 | $845.00 | $126.17 | 14.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 24 | 34 | $544.00 | $76.50 | 14.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 12 | 15 | $150.00 | $1.65 | 1.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 238 | 700 | $105,000 | $47,389 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 82 | 82 | $15,580 | $9,213 | 59.1% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 82 | 288 | $18,720 | $7,993 | 42.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 93 | 131 | $14,410 | $4,693 | 32.6% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 77 | 165 | $6,600 | $1,572 | 23.8% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 37 | 37 | $2,683 | $1,447 | 53.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 84 | 84 | $2,352 | $1,362 | 57.9% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 37 | 37 | $1,295 | $969.50 | 74.9% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 50 | 50 | $1,750 | $939.33 | 53.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 18 | 22 | $1,430 | $236.24 | 16.5% |
About Dr. Ellis Main, D.O
Dr. Ellis Main, D.O is a Rural Health healthcare provider based in Robstown, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1366440919.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ellis Main, D.O has received a total of $9,120 in payments from pharmaceutical and medical device companies, with $51.66 received in 2023. These payments were reported across 630 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,955).
As a Medicare-enrolled provider, Main has provided services to 1,707 Medicare beneficiaries, totaling 3,257 services with total Medicare billing of $166,451. Data is available for 3 years (2020–2022), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Rural Health
- Other Specialties Family Medicine
- Location Robstown, TX
- Active Since 07/08/2005
- Last Updated 10/16/2025
- Taxonomy Code 261QR1300X
- Entity Type Individual
- NPI Number 1366440919
Products in Payments
- FARXIGA (Drug) $913.33
- Ozempic (Drug) $813.44
- XARELTO (Drug) $534.69
- Vascepa (Drug) $466.26
- SOLIQUA (Drug) $271.64
- JARDIANCE (Drug) $234.55
- JANUVIA (Drug) $234.02
- TRULICITY (Drug) $227.25
- INVOKANA (Drug) $223.89
- RYBELSUS (Drug) $211.73
- VRAYLAR (Drug) $209.31
- Victoza (Drug) $207.86
- TRADJENTA (Drug) $198.67
- MYRBETRIQ (Drug) $194.45
- Prolia (Biological) $166.87
- ENTRESTO (Drug) $157.96
- Creon (Drug) $153.73
- EVENITY (Biological) $131.48
- TRELEGY ELLIPTA (Drug) $121.67
- UBRELVY (Drug) $118.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.